The E14 Fund — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Dxlabdxlab.bioDec 2020

DxLab develops multiplex molecular diagnostic technology (LAMP+) for rapid, low-cost point-of-care infectious disease testing, including its DxHub portable testing platform, DxTests, and ready-to-use LAMP master mixes.

BiotechDigital HealthHealthtechMedical DevicesSomerville, US

Louis Kang(Co-founder & Business Development Lead)Fahim Farzadfard(Director)Adam Mullinax(Director)Jeong Seuk Kang(Director)Ho-Jun Suk(Co-founder & CEO)in

BoardCalvin Chin(Director)in

Labbylabbyinc.com in 𝕏Nov 2020

Labby builds optical AI sensors and handheld and in-line devices for real-time milk testing and mastitis detection on dairy farms.

IoTCambridge, US

Anshuman Das(Executive Officer, Director)inJulia Somerdin(Executive Officer, Director)in

Co-investorsTechstars Agritech Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.